Cabaletta Bio Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.35

+0.08 (+2.45%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 81%

Hold 3 19%

Sell 0 0%

Price Target

Analyst Price Target +1,087.8% upside

Low Target $29.42

Average Target $39.79

High Target $58.63

Current Price $3.35

Current
$3.35

Target
$39.79

$29.42 $39.79 avg $58.63

Scenario Analysis

Bear Case

$29.42

778.2%

Low target

Base Case

$39.79

+1,087.8%

Avg target

Bull Case

$58.63

+1,650.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.23

-20.8% from high

52-Week Low

$1.26

+165.9% from low

Target vs 52W High

$39.79

+840.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+20.5%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.2%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+178.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.1%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-88.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-23.9%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.0%